Literature DB >> 18770029

Therapeutic strategy for ischemic stroke.

Toru Yamashita1, Kentaro Deguchi, Yoshihide Sehara, Violeta Lukic-Panin, Hanzhe Zhang, Tatsushi Kamiya, Koji Abe.   

Abstract

Possible strategies for treating ischemic stroke include: (1) Neuroprotection: preventing damaged neurons from undergoing apoptosis in the acute phase of cerebral ischemia; (2) Stem cell therapy: the repair of broken neuronal networks with newly born neurons in the chronic phase of cerebral ischemia. Firstly, we studied the neuroprotective effect of a calcium channel blocker, azelnidipine, or a by-product of heme degradation, biliverdin, in the ischemic brain. These results revealed both azelnidipine and biliverdin had a neuroprotective effect in the ischemic brain through their anti-oxidative property. Secondly, we investigated the role of granulocyte colony-stimulating factor (G-CSF) by administering G-CSF to rats after cerebral ischemia and found G-CSF plays a critical role in neuroprotection. Lastly, we developed a restorative stroke therapy with a bio-affinitive scaffold, which is able to provide an appropriate environment for newly born neurons. In the future, we will combine these strategies to develop more effective therapies for treatment of strokes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770029     DOI: 10.1007/s11064-008-9842-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain.

Authors:  Junya Hayashi; Yasushi Takagi; Hitoshi Fukuda; Takayuki Imazato; Masaki Nishimura; Motoaki Fujimoto; Jun Takahashi; Nobuo Hashimoto; Kazuhiko Nozaki
Journal:  J Cereb Blood Flow Metab       Date:  2006-01-04       Impact factor: 6.200

2.  Reduction of cerebral infarction in rats by biliverdin associated with amelioration of oxidative stress.

Authors:  Kentaro Deguchi; Takeshi Hayashi; Shoko Nagotani; Yoshihide Sehara; Hanzhe Zhang; Atsushi Tsuchiya; Yasuyuki Ohta; Koji Tomiyama; Nobutoshi Morimoto; Masahiro Miyazaki; Nam-Ho Huh; Atsunori Nakao; Tatsushi Kamiya; Koji Abe
Journal:  Brain Res       Date:  2007-10-18       Impact factor: 3.252

3.  Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1beta converting enzyme deficient mice.

Authors:  G Y Yang; G P Schielke; C Gong; Y Mao; H L Ge; X H Liu; A L Betz
Journal:  J Cereb Blood Flow Metab       Date:  1999-10       Impact factor: 6.200

4.  Hyaluronic acid-poly-D-lysine-based three-dimensional hydrogel for traumatic brain injury.

Authors:  W M Tian; S P Hou; J Ma; C L Zhang; Q Y Xu; I S Lee; H D Li; M Spector; F Z Cui
Journal:  Tissue Eng       Date:  2005 Mar-Apr

Review 5.  Reactive oxygen radicals in signaling and damage in the ischemic brain.

Authors:  P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2001-01       Impact factor: 6.200

6.  Antioxidant effects of calcium antagonists in rat brain homogenates.

Authors:  K Yao; Y Ina; K Nagashima; K Ohmori; T Ohno
Journal:  Biol Pharm Bull       Date:  2000-06       Impact factor: 2.233

7.  NXY-059 for acute ischemic stroke.

Authors:  Kennedy R Lees; Justin A Zivin; Tim Ashwood; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; James Grotta; Patrick Lyden; Ashfaq Shuaib; Hans-Göran Hårdemark; Warren W Wasiewski
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

8.  NXY-059 for the treatment of acute ischemic stroke.

Authors:  Ashfaq Shuaib; Kennedy R Lees; Patrick Lyden; James Grotta; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; Tim Ashwood; Warren W Wasiewski; Ugochi Emeribe
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245

9.  Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger.

Authors:  K Abe; S Yuki; K Kogure
Journal:  Stroke       Date:  1988-04       Impact factor: 7.914

10.  Neuroprotective effects of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), an antioxidant in middle cerebral artery occlusion induced focal cerebral ischemia in rats.

Authors:  Shyam S Sharma; Ravinder K Kaundal
Journal:  Neurol Res       Date:  2007-04       Impact factor: 2.448

View more
  5 in total

1.  LIM domain only 4 protein promotes granulocyte colony-stimulating factor-induced signaling in neurons.

Authors:  Mariana Gomez-Smith; Zhaohong Qin; Xun Zhou; Sarah C Schock; Hsiao-Huei Chen
Journal:  Cell Mol Life Sci       Date:  2009-12-10       Impact factor: 9.261

2.  Post-ischemic administration of 5-methoxyindole-2-carboxylic acid at the onset of reperfusion affords neuroprotection against stroke injury by preserving mitochondrial function and attenuating oxidative stress.

Authors:  Jinzi Wu; Zhen Jin; Xiaorong Yang; Liang-Jun Yan
Journal:  Biochem Biophys Res Commun       Date:  2018-02-12       Impact factor: 3.575

3.  Biliverdin protects against cisplatin-induced apoptosis of renal tubular epithelial cells.

Authors:  Qian Lv; Ying Yao; Wei Wang; Wei Xiong; Wen-Hui Liao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-02-03

Review 4.  Chemical Conditioning as an Approach to Ischemic Stroke Tolerance: Mitochondria as the Target.

Authors:  Zhen Jin; Jinzi Wu; Liang-Jun Yan
Journal:  Int J Mol Sci       Date:  2016-03-08       Impact factor: 5.923

Review 5.  Tissue Engineering and Biomaterial Strategies to Elicit Endogenous Neuronal Replacement in the Brain.

Authors:  Erin M Purvis; John C O'Donnell; H Isaac Chen; D Kacy Cullen
Journal:  Front Neurol       Date:  2020-04-28       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.